cancer clinical trials in concord, MA
Bethke Cancer Center at Emerson Hospital
Concord, Massachusetts 01742 Breast Cancer
|
Commonwealth Hematology-Oncology, PC - Concord
Concord, Massachusetts 01742 Breast Cancer
|
Bethke Cancer Center at Emerson Hospital
Concord, Massachusetts 01742 Breast Cancer
|
Emerson Hospital
Concord, Massachusetts 01742 Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
|
Bethke Cancer Center at Emerson Hospital
Concord, Massachusetts 01742 Chemotherapeutic Agent Toxicity, Head and Neck Cancer, Mucositis, Radiation Toxicity, Xerostomia
|
Commonwealth Hematology Oncology PC-Concord
Concord, Massachusetts 01742 Adenocarcinoma of the Colon, Stage II Colon Cancer
|
Commonwealth Hematology Oncology PC-Concord
Concord, Massachusetts 01742 Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
|
Commonwealth Hematology-Oncology, PC - Concord
Concord, Massachusetts 01742 Breast Cancer
|
GTx Investigative Site
Concord, Massachusetts 01742 Muscle Wasting, Non Small Cell Lung Cancer
|
GTx Investigative Site
Concord, Massachusetts 01742 Muscle Wasting, Non-Small Cell Lung Cancer
|
Bethke Cancer Center at Emerson Hospital
Concord, Massachusetts 01742 Anal Cancer
|
Bethke Cancer Center at Emerson Hospital
Concord, Massachusetts 01742 Breast Cancer, Osteoporosis
|
Emerson Hospital
Concord, Massachusetts 01742 Prostate Cancer
|